WHITNEY MORGAN: Open Payments
NPI 1740922400 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 73 payments from 14 companies in 2025. Trend: 2023 $537 · 2024 $1,120 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $148 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Celltrion USA Inc. | 3 | $58 |
| Janssen Biotech, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 7 | $52 |
| QOL Medical, LLC | 3 | $49 |
| Lilly USA, LLC | 2 | $49 |
| PFIZER INC. | 3 | $47 |
| Intercept Pharmaceuticals, Inc. | 3 | $42 |
Products named: RINVOQ, ENTYVIO, DUPIXENT, VEGZELMA, TREMFYA, VOQUEZNA, Sucraid, OMVOH.
Industry payments across LA — which companies pay providers there.
